Interested in new trials?
Get alerts for new trials in your area by subscribing now
What is prurigo nodularis?
Prurigo nodularis, often shortened to PN, is a long term skin disease that causes hard, raised, rough nodules that itch intensely. The itch comes from overactive immune signals in the skin, called type 2 inflammation, along with changes in the skin's nerves, the same inflammation pathway seen in atopic dermatitis, which PN patients also have at higher rates. Scratching creates more nodules, and those itch too, so the cycle feeds itself, often bad enough to wreck sleep.
A few things make PN research unusual. There's no blood test or scan for itch, so studies ask participants to rate their worst itch on a 0 to 10 scale, and that rating is the main result the whole study rests on. The field is also very young, the first approved medicine for PN arrived only a few years ago, so today's trials are measured against a standard that barely existed before that. There's also a known gap: one study of 909 patients found Black patients were more than 3 times as likely to have PN as white patients, so researchers need study groups that reflect everyone living with the disease.
Can prurigo nodularis be cured?
There is no cure for prurigo nodularis today. Treatment aims at controlling the itch and the nodules instead, and for some people the condition does slowly settle down on its own, though that can take months or years. Two medicines are now approved specifically for PN, the first of them only in 2022, and oral options are being tested in studies right now.
Do prurigo nodularis trial participants get paid?
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.
Curious whether clinical trials pay participants? Here's how compensation actually works.
Who can participate in prurigo nodularis clinical trials?
It depends on the study. PN has no staging system, so trials recruit by severity, and most look for adults with moderate to severe disease. Doctors judge severity mostly by how many nodules you have and how strong the itch is, plus a doctor-scored scale called IGA that runs from clear to severe. In practice that means a certain number of nodules plus a high itch score. Many studies also ask whether topical treatments already failed for you.
But the mix on this page is wider than that. One study tests an oral tablet in adults. One follows people already on an approved biologic. One is open to children and teens from 6 months to 18 years old. The quickest way to see what fits is to ask your dermatologist how they grade your PN. Researchers also want study groups that reflect who carries the heaviest share of this disease, since Black patients are diagnosed with PN far more often than white patients. Eligibility always varies by study.
Considering volunteering in a clinical trial? Explore our comprehensive guide to learn more about why people choose to volunteer and the impact you can make in advancing medical research. Discover the process of volunteering, what to consider before applying and the potential benefits and risks involved.
Types of prurigo nodularis clinical trials
Clinical trials for prurigo nodularis encompass a range of study types, each focusing on different aspects of the condition and treatment strategies. These trials explore various approaches to managing and treating PN, aiming to improve understanding and develop effective therapies tailored to the needs of patients.
Treatment trials
These trials aim to assess the effectiveness of newly developed medications, topical treatments, or medical procedures in managing the symptoms of prurigo nodularis and ultimately improving the outcomes for patients. Researchers carefully evaluate how these interventions impact the severity and frequency of PN symptoms, such as itching and the formation of nodules, as well as their overall impact on patient well-being and quality of life.
Diagnostic studies
Diagnostic Studies concentrate on improving diagnostic tools and techniques to accurately identify prurigo nodularis and differentiate it from other skin conditions. By enhancing diagnostic accuracy, healthcare providers can ensure timely and precise diagnosis, leading to more effective management of PN.
Quality of life studies
Quality of life studies focus on interventions designed to enhance the overall well-being and quality of life of individuals living with prurigo nodularis. These studies may include psychosocial support programs, symptom management strategies, or other interventions designed to address the physical, emotional, and social aspects of living with PN.
Interested in learning more about prurigo nodularis (PN)? Dive into our comprehensive guide to discover insights into this condition's nature, its symptoms, potential causes, and more!
How to enroll in a prurigo nodularis clinical trial
Enrolling in a clinical trial for prurigo nodularis through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.